Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial.
Emerging Therapeutic Strategies for Fragile X Syndrome: Q&A.
Language processing skills linked to FMR1 variation: A study of gaze-language coordination during rapid automatized naming among women with the FMR1 premutation.
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Emerging Therapeutic Strategies for Fragile X Syndrome: Q&A.
Emerging Therapeutic Strategies for Fragile X Syndrome: Q&A. ACS Chem Neurosci. 2022 Dec 21; 13(24):3544-3546.
View in:
PubMed
authors with profiles
Elizabeth M Berry-Kravis